Advertisement
Screener

AirSculpt Technologies, Inc. (AIRS) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

AirSculpt Technologies, Inc. Financing Cash Flow

AirSculpt Technologies, Inc. (AIRS) reported Financing Cash Flow of $6.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10

  • AirSculpt Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.60M.
  • AirSculpt Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.02M.
  • AirSculpt Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $5.63M, a 83.01% increase year-over-year.
  • AirSculpt Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$2.38M.
  • AirSculpt Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$478.00K, a 175.87% decline from fiscal 2024.
  • AirSculpt Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $630.00K.
  • AirSculpt Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$13.39M.
  • AirSculpt Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$27.26M.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30$3.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$6.62M
10-Q · filed 2026-08-10
$12.25M
derived: sum of 3 quarters · filed 2026-08-10
$9.88M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$3.02M
10-Q · filed 2026-05-08
$8.65M
derived: sum of 2 quarters · filed 2026-05-08
$6.28M
derived: sum of 3 quarters · filed 2026-05-08
$4.19M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$5.63M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06
$3.25M
derived: sum of 2 quarters · filed 2026-04-06
$1.17M
derived: sum of 3 quarters · filed 2026-08-10
-$478.00K
10-K/A · filed 2026-04-06
2025-09-30-$2.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$4.46M
derived: sum of 2 quarters · filed 2026-08-10
-$6.11M
10-Q · filed 2025-11-07
-$3.03M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$2.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$3.73M
10-Q · filed 2026-08-10
-$654.00K
derived: sum of 3 quarters · filed 2026-08-10
-$1.48M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$1.65M
10-Q · filed 2026-05-08
$1.43M
derived: sum of 2 quarters · filed 2026-05-08
$604.00K
derived: sum of 3 quarters · filed 2026-05-08
$77.00K
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$3.08M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06
$2.25M
derived: sum of 2 quarters · filed 2026-04-06
$1.73M
derived: sum of 3 quarters · filed 2026-04-06
$630.00K
10-K/A · filed 2026-04-06
2024-09-30-$825.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$1.35M
derived: sum of 2 quarters · filed 2025-11-07
-$2.45M
10-Q · filed 2025-11-07
-$3.88M
derived: sum of 4 quarters · filed 2026-04-06
2024-06-30-$527.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01
-$1.62M
10-Q · filed 2025-08-01
-$3.06M
derived: sum of 3 quarters · filed 2026-04-06
-$13.70M
derived: sum of 4 quarters · filed 2026-04-06
2024-03-31-$1.10M
10-Q · filed 2025-05-02
-$2.53M
derived: sum of 2 quarters · filed 2026-04-06
-$13.17M
derived: sum of 3 quarters · filed 2026-04-06
-$13.75M
derived: sum of 4 quarters · filed 2026-04-06
2023-12-31-$1.44M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06
-$12.07M
derived: sum of 2 quarters · filed 2026-04-06
-$12.65M
derived: sum of 3 quarters · filed 2026-04-06
-$13.39M
10-K/A · filed 2026-04-06
2023-09-30-$10.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
-$11.22M
derived: sum of 2 quarters · filed 2024-11-08
-$11.95M
10-Q · filed 2024-11-08
-$14.38M
derived: sum of 4 quarters · filed 2025-03-14
2023-06-30-$579.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$1.32M
10-Q · filed 2024-08-09
-$3.75M
derived: sum of 3 quarters · filed 2025-03-14
-$27.14M
derived: sum of 4 quarters · filed 2025-03-14
2023-03-31-$737.00K
10-Q · filed 2024-05-10
-$3.17M
derived: sum of 2 quarters · filed 2025-03-14
-$26.56M
derived: sum of 3 quarters · filed 2025-03-14
-$27.07M
derived: sum of 4 quarters · filed 2025-03-14
2022-12-31-$2.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
-$25.82M
derived: sum of 2 quarters · filed 2025-03-14
-$26.33M
derived: sum of 3 quarters · filed 2025-03-14
-$27.26M
10-K · filed 2025-03-14
2022-09-30-$23.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$23.90M
derived: sum of 2 quarters · filed 2023-11-13
-$24.83M
10-Q · filed 2023-11-13
-$12.12M
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30-$509.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
-$1.43M
10-Q · filed 2023-08-11
$11.27M
derived: sum of 3 quarters · filed 2024-02-27
$11.27M
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31-$924.00K
10-Q · filed 2023-05-12
$11.78M
derived: sum of 2 quarters · filed 2024-02-27
$11.78M
derived: sum of 3 quarters · filed 2024-02-27
$1.34M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$12.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$12.71M
derived: sum of 2 quarters · filed 2024-02-27
$2.27M
derived: sum of 3 quarters · filed 2024-02-27
-$4.55M
10-K · filed 2024-02-27
2021-09-30$10.00
10-Q · filed 2021-12-03
-$10.44M
derived: sum of 2 quarters · filed 2022-08-12
-$17.25M
10-Q · filed 2022-11-14
2021-06-30-$10.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$14.20M
10-Q · filed 2022-08-12
2021-03-31-$3.76M
10-Q · filed 2022-05-13
2020-12-31-$5.02M
10-K · filed 2023-03-10
2019-12-31-$783.00K
10-K · filed 2022-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
LifeMD, Inc. (LFMD)United States$0.141B982.53
SBC Medical Group Holdings Inc (SBC)United States$0.487B
Teladoc Health, Inc. (TDOC)United States$1.114B-8.68